|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yap TA, Carden CP and Kaye SB: Beyond
chemotherapy: Targeted therapies in ovarian cancer. Nat Rev Cancer.
9:167–181. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dunn GP, Old LJ and Schreiber RD: The
immunobiology of cancer immunosurveillance and immunoediting.
Immunity. 21:137–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shah CA, Allison KH, Garcia RL, Gray HJ,
Goff BA and Swisher EM: Intratumoral T cells, tumor-associated
macrophages, and regulatory T cells: Association with p53
mutations, circulating tumor DNA and survival in women with ovarian
cancer. Gynecol Oncol. 109:215–219. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Milne K, Köbel M, Kalloger SE, Barnes RO,
Gao D, Gilks CB, Watson PH and Nelson BH: Systematic analysis of
immune infiltrates in high-grade serous ovarian cancer reveals
CD20, FoxP3 and TIA-1 as positive prognostic factors. PloS One.
4:e64122009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adams SF, Levine DA, Cadungog MG, Hammond
R, Facciabene A, Olvera N, Rubin SC, Boyd J, Gimotty PA and Coukos
G: Intraepithelial T cells and tumor proliferation: Impact on the
benefit from surgical cytoreduction in advanced serous ovarian
cancer. Cancer. 115:2891–2902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kryczek I, Wei S, Zhu G, Myers L, Mottram
P, Cheng P, Chen L, Coukos G and Zou W: Relationship between B7-H4,
regulatory T cells, and patient outcome in human ovarian carcinoma.
Cancer Res. 67:8900–8905. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsuzaki J, Gnjatic S, Mhawech-Fauceglia
P, Beck A, Miller A, Tsuji T, Eppolito C, Qian F, Lele S, Shrikant
P, et al: Tumor-infiltrating NY-ESO-1-specific CD8+ T
cells are negatively regulated by LAG-3 and PD-1 in human ovarian
cancer. Proc Natl Acad Sci USA. 107:7875–7880. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Witz IP: The tumor microenvironment: The
making of a paradigm. Cancer Microenviron 2 Suppl. 1:9–17. 2009.
View Article : Google Scholar
|
|
10
|
Allavena P, Sica A, Solinas G, Porta C and
Mantovani A: The inflammatory micro-environment in tumor
progression: The role of tumor-associated macrophages. Crit Rev
Oncol Hematol. 66:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yaal-Hahoshen N, Shina S, Leider-Trejo L,
Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I and
Ben-Baruch A: The chemokine CCL5 as a potential prognostic factor
predicting disease progression in stage II breast cancer patients.
Clin Cancer Res. 12:4474–4480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Deavers M, Patenia R, Bassett RL
Jr, Mueller P, Ma Q, Wang E and Freedman RS: Monocyte/macrophage
and T-cell infiltrates in peritoneum of patients with ovarian
cancer or benign pelvic disease. J Transl Med. 4:302006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mantovani A and Allavena P: The
interaction of anticancer therapies with tumor-associated
macrophages. J Exp Med. 212:435–445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fontenot JD, Gavin MA and Rudensky AY:
Foxp3 programs the development and function of
CD4+CD25+ regulatory T cells. Nat Immunol.
4:330–336. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ouyang W, Kolls JK and Zheng Y: The
biological functions of T helper 17 cell effector cytokines in
inflammation. Immunity. 28:454–467. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Z, Ding J, Pang N, Du R, Meng W, Zhu
Y, Zhang Y, Ma C and Ding Y: The Th17/Treg balance and the
expression of related cytokines in Uygur cervical cancer patients.
Diagn Pathol. 8:612013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Charbonneau B, Moysich KB, Kalli KR, Oberg
AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM,
Fridley BL, et al: Large-scale evaluation of common variation in
regulatory T cell-related genes and ovarian cancer outcome. Cancer
Immunol Res. 2:332–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng
Q and Wang H, Chen J and Wang H: Tumor-associated macrophages
recruit CCR6+ regulatory T cells and promote the
development of colorectal cancer via enhancing CCL20 production in
mice. PloS One. 6:e194952011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zou W: Regulatory T cells, tumour immunity
and immunotherapy. Nat Rev Immunol. 6:295–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiaodan Meng, Volkmar Müller, Karin
Milde-Langosch, Fabian Trillsch, Klaus Pantel and Heidi
Schwarzenbach: Circulating cell-free mir-373, mir-200a, mir-200b
and mir-200c in patients with epithelial ovarian cancer. Adv Exp
Med Biol. 924:3–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Winter WE III, Maxwell GL, Tian C, Carlson
JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F and
McGuire WP: Gynecologic Oncology Group Study: Prognostic factors
for stage III epithelial ovarian cancer: A Gynecologic Oncology
Group Study. J Clin Oncol. 25:3621–3627. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colvin EK: Tumor-associated macrophages
contribute to tumor progression in ovarian cancer. Front Oncol.
4:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Salvi S, Segalla F, Rao S, Arienti F,
Sartori M, Bratina G, Caronni E, Anichini A, Clemente C, Parmiani
G, et al: Overexpression of the T-cell receptor beta-chain variable
region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer
Res. 55:3374–3379. 1995.PubMed/NCBI
|
|
24
|
Curiel TJ, Coukos G, Zou L, Alvarez X,
Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L,
Burow M, et al: Specific recruitment of regulatory T cells in
ovarian carcinoma fosters immune privilege and predicts reduced
survival. Nat Med. 10:942–949. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barnett B, Kryczek I, Cheng P, Zou W and
Curiel TJ: Regulatory T cells in ovarian cancer: Biology and
therapeutic potential. Am J Reprod Immunol. 54:369–377. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dietl J, Engel JB and Wischhusen J: The
role of regulatory T cells in ovarian cancer. Int J Gynecol Cancer.
17:764–770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eljaszewicz A, Wiese M, Helmin-Basa A,
Jankowski M, Gackowska L, Kubiszewska I, Kaszewski W, Michalkiewicz
J and Zegarski W: Collaborating with the enemy: Function of
macrophages in the development of neoplastic disease. Mediators
Inflamm. 2013:8313872013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sasaki A, Tanaka F, Mimori K, Inoue H, Kai
S, Shibata K, Ohta M, Kitano S and Mori M: Prognostic value of
tumor-infiltrating FOXP3+ regulatory T cells in patients
with hepatocellular carcinoma. Eur J Surg Oncol. 34:173–179. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mhawech-Fauceglia P, Wang D, Ali L, Lele
S, Huba MA, Liu S and Odunsi K: Intraepithelial T cells and
tumor-associated macrophages in ovarian cancer patients. Cancer
Immun. 13:12013.PubMed/NCBI
|
|
30
|
Sato E, Olson SH, Ahn J, Bundy B,
Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone
C, et al: Intraepithelial CD8+ tumor-infiltrating
lymphocytes and a high CD8+/regulatory T cell ratio are
associated with favorable prognosis in ovarian cancer. Proc Natl
Acad Sci USA. 102:18538–18543. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Klimp AH, Hollema H, Kempinga C, van der
Zee AG, de Vries EG and Daemen T: Expression of cyclooxygenase-2
and inducible nitric oxide synthase in human ovarian tumors and
tumor-associated macrophages. Cancer Res. 61:7305–7309.
2001.PubMed/NCBI
|
|
32
|
Kawamura K, Komohara Y, Takaishi K,
Katabuchi H and Takeya M: Detection of M2 macrophages and
colony-stimulating factor 1 expression in serous and mucinous
ovarian epithelial tumors. Pathol Int. 59:300–305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pittet MJ: Behavior of immune players in
the tumor microenvironment. Curr Opin Oncol. 21:53–59. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zamarron BF and Chen W: Dual roles of
immune cells and their factors in cancer development and
progression. Int J Biol Sci. 7:651–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Leffers N, Gooden MJ, de Jong RA,
Hoogeboom BN, ten Hoor KA, Hollema H, Boezen HM, van der Zee AG,
Daemen T and Nijman HW: Prognostic significance of
tumor-infiltrating T-lymphocytes in primary and metastatic lesions
of advanced stage ovarian cancer. Cancer Immunol Immunother.
58:449–459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao
YH, Chu CY, Tsai TF, Chiu HC, Dai YS, Inoue H, et al:
Tumor-associated macrophage-induced invasion and angiogenesis of
human basal cell carcinoma cells by cyclooxygenase-2 induction. J
Invest Dermatol. 129:1016–1025. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shieh YS, Hung YJ, Hsieh CB, Chen JS, Chou
KC and Liu SY: Tumor-associated macrophage correlated with
angiogenesis and progression of mucoepidermoid carcinoma of
salivary glands. Ann Surg Oncol. 16:751–760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Toge H, Inagaki T, Kojimoto Y, Shinka T
and Hara I: Angiogenesis in renal cell carcinoma: The role of
tumor-associated macrophages. Int J Urol. 16:801–807. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Soeda S, Nakamura N, Ozeki T, Nishiyama H,
Hojo H, Yamada H, Abe M and Sato A: Tumor-associated macrophages
correlate with vascular space invasion and myometrial invasion in
endometrial carcinoma. Gynecol Oncol. 109:122–128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gnerlich JL, Mitchem JB, Weir JS, Sankpal
NV, Kashiwagi H, Belt BA, Porembka MR, Herndon JM, Eberlein TJ,
Goedegebuure P and Linehan DC: Induction of Th17 cells in the tumor
microenvironment improves survival in a murine model of pancreatic
cancer. J Immunol. 185:4063–4071. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hou F, Li Z, Ma D, Zhang W, Zhang Y, Zhang
T, Kong B and Cui B: Distribution of Th17 cells and
Foxp3-expressing T cells in tumor-infiltrating lymphocytes in
patients with uterine cervical cancer. Clin Chim Acta.
413:1848–1854. 2012. View Article : Google Scholar : PubMed/NCBI
|
